東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Advances in pharma business manageme...

Schweizer, Lars.

FindBook

Google Book

Amazon

博客來

Advances in pharma business management and research.. Volume 1

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Advances in pharma business management and research./ edited by Lars Schweizer ... [et al.].
其他作者:	Schweizer, Lars.
出版者:	Cham :Springer International Publishing : : 2020.,
面頁冊數:	x, 85 p. :ill., digital ;24 cm.
內容註:	Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee's Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) - A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.
Contained By:	Springer eBooks
標題:	Pharmaceutical industry - Management. -
電子資源:	https://doi.org/10.1007/978-3-030-35918-8
ISBN:	9783030359188

Advances in pharma business management and research.. Volume 1
Advances in pharma business management and research.Volume 1[electronic resource] /edited by Lars Schweizer ... [et al.]. - Cham :Springer International Publishing :2020. - x, 85 p. :ill., digital ;24 cm.

Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee's Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) - A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.

Open access.

This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master's theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.

ISBN: 9783030359188

Standard No.: 10.1007/978-3-030-35918-8doiSubjects--Topical Terms:

802042
Pharmaceutical industry
--Management.

LC Class. No.: HD9665.5 / .A383 2020

Dewey Class. No.: 615.190068

Advances in pharma business management and research.. Volume 1
LDR:02834nmm a2200337 a 4500 001 2216012
003 DE-He213
005 20200707170507.0
006 m d
007 cr nn 008maaau
008 201120s2020 sz s 0 eng d
020 $a 9783030359188 $q (electronic bk.)
020 $a 9783030359171 $q (paper)
024 7 $a 10.1007/978-3-030-35918-8 $2 doi
035 $a 978-3-030-35918-8
040 $a GP $c GP
041 0 $a eng
050 4 $a HD9665.5 $b .A383 2020
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 615.190068 $2 23
090 $a HD9665.5 $b .A244 2020
245 0 0 $a Advances in pharma business management and research. $n Volume 1 $h [electronic resource] / $c edited by Lars Schweizer ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a x, 85 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee's Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) - A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.
506 $a Open access.
520 $a This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master's theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.
650 0 $a Pharmaceutical industry $x Management. $3 802042
650 1 4 $a Pharmaceutical Sciences/Technology. $3 1001579
650 2 4 $a Health Care Management. $3 2054807
650 2 4 $a Medical Law. $3 897066
650 2 4 $a Pharmacy. $3 636101
650 2 4 $a Pharmacoeconomics and Health Outcomes. $3 2089175
700 1 $a Schweizer, Lars. $3 3448014
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-35918-8
950 $a Biomedical and Life Sciences (Springer-11642)